Novel gene discovery is the fundamental goal of the Center for Mendelian Genomics program. Our case review process is designed to select cases that will give us the best chance for gene discovery.
Various factors are considered when prioritizing cases to accept, including cases with:
• Likely Mendelian cause
• Prescreening for known genetic causes
• Likely recessive or de novo dominant genetic inheritance
• Detailed clinical data available
• Multiple affected family members available for testing
• Samples from a disease relevant tissue for RNA-seq
Start Cohort Application
To initiate an application for sequencing with the CMG, we ask that you first fill out the case review form, which consists of entering information about the cohort and regulatory requirements.
The form will guide you to describe your cohort, explain the existing information about the genetic architecture, and provide the number of available samples. Our case review team will review this form and notify you if the cohort is a good fit for CMG.
This form will also initially require the following documents. Previews of regulatory documents are available below.
Template Informed Consent Form
Material Transfer Agreement - The Broad does not require an MTA in order to receive samples. If your institution requires that an MTA to be put in place, please provide us with a template for your institutution.
Research Attestation (International)-
We need to establish that your institution authorizes sending samples to the Broad Institute in the US. Someone from your institution with signature authority must sign the Research Attestation. Alternatively, if your institution prefers or requires model clauses, please let us know.